𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Budesonide combined with ursodeoxycholic acid in primary biliary cirrhosis with advanced liver damage

✍ Scribed by B. Pagán; J.C. Erdozain; C. Comas; S. Martín-Chávarri; M. López; J.F. Gómez-Cerezo

Book ID
116431669
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
212 KB
Volume
17
Category
Article
ISSN
0953-6205

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral budesonide in the treatment of pati
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
✍ Paul Angulo; Roberta A. Jorgensen; Jill C. Keach; E. Rolland Dickson; Coleman Sm 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC). However, some patients show an incomplete response to UDCA therapy. Treatment with corticosteroids may be of benefit although at the expense of systemic side effects. Budesonid

Ursodeoxycholic acid inhibits eosinophil
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis
✍ Kiyoshi Yamazaki; Kazuyuki Suzuki; Atsushi Nakamura; Shunichi Sato; Keith D. Lin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 1 views

Eosinophilia is a distinctive feature of primary biliary cirrhosis (PBC), especially in its early stages. Intriguingly, treatment with ursodeoxycholic acid (UDCA) ameliorates eosinophilia as well as liver tests in patients with PBC. It remains unknown, however, whether eosinophils in PBC patients ar